The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Stage Information

Added text about the current use of standard risk-group and high-risk group stratification for patients with multiple myeloma; the newer stratification has been derived from retrospective analyses and requires prospective validation (cited Dispenzieri et al. as reference 7). Also added examples of cytogenetic findings that define standard risk and high risk, respectively.

Multiple Myeloma

This section was extensively revised.

Back to Top

< Previous Section  |  Next Section >